Deeptech health startup NiramaiHealth Analytix has raised research funding from UK-based development finance institution and impact investor CDC for NIRAMAI FeverTest, which was launched last year.
NIRAMAI FeverTest is a smart software that enables screening for COVID-19 symptoms in public places by leveraging computer vision and AI to analyse and monitor crowd compliance to COVID-19
guidelines.
